Showing results (351-360 of 528) with videos related to
Sort By:
Pageof 53
Nature Microbiology|November 7, 2018
Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralizationQingbing Zheng, Rui Zhu, Longfa Xu, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.Science Translational Medicine|November 22, 2019
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.The Journal of Infectious Diseases|August 15, 2018
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory IllnessNatalie I Mazur, Nicole M Horsley, Janet A Englund, et al.Nature Communications|February 9, 2020
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responsesSeyhan Boyoglu-Barnum, Geoffrey B Hutchinson, Jeffrey C Boyington, et al.The Journal of Infectious Diseases|May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn InfantsElizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.Viruses|August 22, 2018
The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron TomographyZunlong Ke, Rebecca S Dillard, Tatiana Chirkova, et al.Cell Host & Microbe|October 5, 2021
Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunityRita E Chen, Brittany K Smith, John M Errico, et al.Vaccines|August 28, 2025
Systemic and Mucosal Humoral Immune Responses to Lumazine Synthase 60-mer Nanoparticle SARS-CoV-2 VaccinesCheng Cheng, Jeffrey C Boyington, Edward K Sarfo, et al.The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.Pageof 53